Paediatric invasive group A streptococcal infections and associations with viral infections in 15 European countries after lifting non-pharmaceutical interventions against SARS-CoV-2: an interrupted time-series analysis



Lenglart, L, Özmen, I ORCID: 0000-0002-1014-7175, Aguilera-Alonso, D, Blazquez-Gamero, D, Boeddha, NP, Buddingh, EP, Buonsenso, D, Calvo, C ORCID: 0000-0002-6503-3423, Castagnoli, R ORCID: 0000-0003-0029-9383, Daina, M
et al (show 71 more authors) (2025) Paediatric invasive group A streptococcal infections and associations with viral infections in 15 European countries after lifting non-pharmaceutical interventions against SARS-CoV-2: an interrupted time-series analysis Lancet Regional Health Europe, 59. 101497-. ISSN 2666-7762, 2666-7762

[thumbnail of Manuscript PEGASUS final submitted.docx] Microsoft Word (OpenXML)
Manuscript PEGASUS final submitted.docx - Submitted version

Download (121kB)

Abstract

Background: After lifting non-pharmaceutical interventions (NPIs) against the transmission of SARS-CoV-2, various countries experienced an increase in invasive Group A Streptococcal (iGAS) infections. We aimed to characterise the paediatric outbreak across Europe and to analyse the influence of viral infections. Methods: We conducted an interrupted time-series analysis based on data from 15 European countries from the PEGASUS consortium. We assessed the evolution of the number of iGAS cases aged 1 month to 18 years between 01/01/2018 and 03/31/2024, comparing the post-NPIs period (01-04-2022 until 31-03-2024) to the baseline period (01-01-2018 until 31-03-2020). Further analyses were performed by country, clinical phenotype, age and severity, including sensitivity analyses. We then explored whether certain iGAS phenotypes correlated with trends in RSV, influenza and VZV across countries over time using Google Trends data. Findings: We included 2091 iGAS cases over the study period; 79 children (3.6%) died and 580 (27.7%) required PICU admission. We estimated an overall increase of +229.8% (95% CI (141.9–341.6)) among iGAS cases from October 2022 to March 2024, compared to the baseline period. The observed increases varied across clinical phenotypes, ranging from +62.7% (95% CI (8.3–157.9)) for osteo-articular infections to +238.7% (95% CI 75.8–464.8) for pneumonia. We observed a strong correlation between the incidence of iGAS pneumonia and RSV (Rho: 0.57, 95% CI [0.11–0.79]) and influenza (Rho 0.69, 95% CI 0.35–0.87); and between skin and soft tissue infections and VZV (Rho: 0.73, 95% CI [0.42–0.89]). Interpretation: The patterns observed across Europe during this outbreak demonstrate an association between respiratory viruses as well as VZV, and iGAS. Funding: This study has received funding from ESPID, INOPSU and the Northwest Clinics. The COPP study group was supported by grants of the Dutch National Health Council (ZonMW) project number 10430072110007 and the Christine Bader Foundation.

Item Type: Article
Uncontrolled Keywords: Streptococcus pyogenes, Group A streptococcus, Invasive streptococcal disease, Outbreak, Paediatrics, Viral infections, Viruses, Influenza, Flu, RSV, Respiratory syncytial virus, VZV, Varicella, Immunity debt, Non pharmaceutical interventions, Europe
Divisions: Faculty of Health & Life Sciences
Faculty of Health & Life Sciences > Inst. Infection, Vet & Ecological Sciences
Faculty of Health & Life Sciences > Inst. Infection, Vet & Ecological Sciences > Inst. Infection, Vet & Ecological Sciences (T&R Staff)
Faculty of Health & Life Sciences > Inst. Infection, Vet & Ecological Sciences > Clinical Infection, Microbiology & Immunology
Depositing User: Symplectic Admin
Date Deposited: 29 Oct 2025 16:11
Last Modified: 28 Feb 2026 20:51
DOI: 10.1016/j.lanepe.2025.101497
Related Websites:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3195080
Disclaimer: The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.